By Julia Karow

Life Technologies' Ion Torrent
plans to launch 2x200-base paired-end reads and 400-base fragment reads for the PGM later this year, along with new sets of custom and fixed-content AmpliSeq panels for targeted resequencing.

As some of its customers are beginning to use the instrument for clinical applications, the company also said that it plans to submit the PGM for clearance by the US Food and Drug Administration and CE-IVD certification this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.